← Back to guidelines
Oncology106 papers

Atypical teratoid/rhabdoid tumor

Last edited: 4/15/2026

Overview

Atypical teratoid/rhabdoid tumor (ATRT) is a rare and aggressive neoplasm predominantly affecting children, typically presenting intracranially with a dismal prognosis due to its rapid growth and resistance to therapy 1.

Diagnosis

  • Imaging studies (MRI, CT) essential for initial detection and localization 1.
  • Histopathological examination required for definitive diagnosis, identifying characteristic rhabdoid cells 1.
  • Immunohistochemistry often confirms diagnosis by detecting markers like SMARCB1/INI1 loss 1.
  • Management

  • Surgery: Primary treatment aimed at maximal resection 1.
  • Chemotherapy: Combination regimens often used, though specific protocols vary; examples include vincristine, cyclophosphamide, and doxorubicin 1.
  • Radiotherapy: Considered in specific cases, such as spinal ATRT in adults, though evidence is limited 1.
  • Special Populations

  • Pediatrics: Primary focus of ATRT cases; treatment strategies centered around aggressive multimodal therapy 1.
  • Adults: Rare; case reports suggest radiotherapy may play a role in management, particularly for spinal involvement 1.
  • Key Recommendations

  • Maximal surgical resection should be pursued whenever feasible for ATRT patients (Evidence: Expert opinion 1).
  • Multimodal therapy including chemotherapy is recommended, though specific regimens should be tailored based on institutional protocols and patient factors (Evidence: Expert opinion 1).
  • Radiotherapy may be considered in specific adult cases, particularly for spinal ATRT, given limited evidence (Evidence: Weak 1).
  • References

    1 Ayrak FB, Arslan SA, Tezcan Y. Spinal ATRT and Radiotherapy Case Report in an Adult Man. Oncology (Williston Park, N.Y.) 2023. link

    Original source

    1. [1]
      Spinal ATRT and Radiotherapy Case Report in an Adult Man.Ayrak FB, Arslan SA, Tezcan Y Oncology (Williston Park, N.Y.) (2023)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG